Where is the line between on-site and remote work?
At the medicine itself, and at the responsible pharmacist. Nothing in the Medicines Act 1968 or the Human Medicines Regulations 2012 says where a pharmacist must sit to read a prescription, speak to a patient or write one. What the law fixes is narrower. Prescription-only and pharmacy medicines must be sold or supplied at or from a registered pharmacy, by or under the supervision of a pharmacist. And every registered pharmacy must have a responsible pharmacist in charge, who may be absent for no more than two hours in business hours.
Everything else is governance. The GPhC's guidance for pharmacies providing services at a distance, published in February 2025, takes remote working as a given. Its section on staff requires that everyone is trained and competent. It adds that this "includes staff who work remotely and are not in the pharmacy itself". Its section on accountability covers services with more than one pharmacist. In that case "it should be clear which pharmacist is accountable and responsible for each part of the service". The regulator's concern is not location. It is whether someone answers for each step.
The table sets out the line as the law and the GPhC guidance draw it. It applies to bricks-and-mortar and distance-selling pharmacies alike, because both are registered premises with the same standards. For the wider rulebook, see the GPhC's standards for online pharmacies.
| Activity | Can it be done off site? | Why |
|---|---|---|
| Responsible pharmacist role | No. | 2008 Regulations: one premises, two-hour absence limit, must be contactable and able to return. |
| Supervising a sale or supply | No. | Regulation 220 requires supply at or from the premises under a pharmacist's supervision. GPhC: no remote supervision. |
| Assembly, labelling, accuracy check of the item, hand-out | No. | The medicine is on the premises. Hand-out in the pharmacist's absence needs an authorised person on site. |
| Clinical check of a prescription | Yes, by a pharmacist who is not the RP on duty. | No statute fixes the location. GPhC guidance covers remote staff and requires clear accountability. |
| Prescribing and consultations | Yes. | GPhC distance guidance: registered prescriber, two-way communication, independent verification for higher-risk medicines. |
| Order screening, customer service, admin | Yes. | Not a sale or supply. Data protection and confidentiality rules apply in full. |
Does the responsible pharmacist have to be on the premises?
Yes, and this is the rule the supervision reform deliberately left alone. The Medicines (Pharmacies) (Responsible Pharmacist) Regulations 2008, in force since 1 October 2009, cap absence at two hours during the pharmacy's business hours. During any absence the RP must, where reasonably practicable, stay contactable and be able to return "with reasonable promptness" if the safe running of the pharmacy needs it. If that is not practicable, another pharmacist must be available and contactable to advise staff.
The DHSC consultation that produced the 2025 Order was blunt about why. It said "physical presence of a pharmacist within a retail pharmacy is critical", and that the proposals were "not a move towards allowing pharmacists to remotely supervise a community pharmacy". The GPhC's FAQs on the new legislation repeat the point. The changes "are not intended to allow a Responsible Pharmacist to be absent from the pharmacy for longer than two hours". And they "do not allow for the Responsible Pharmacist to supervise pharmacy staff remotely".
The GPhC's draft rules, consulted on from 17 December 2025 to 25 March 2026, keep the same shape. They continue the "one pharmacy" rule. An RP "can only be responsible for one pharmacy premises at any given time", and cannot perform the role anywhere other than the pharmacy where they are signed in. They keep the two-hour limit, and apply it as a shared total where two RPs cover a day. The regulator has not yet said when the final rules will be published.
Can a pharmacist do clinical checks from home?
Yes, as long as the pharmacist doing them is not the RP on duty and the supply itself stays on site. The clinical check is not a defined legal act. The law regulates the sale or supply, which must be made at or from the registered premises under the supervision of a pharmacist. A second pharmacist reviewing prescriptions from another location does not change that, provided the pharmacist on the premises supervises the supply and a responsible pharmacist is signed in.
Online pharmacies have worked this way for years, and the February 2025 guidance is written around it. It expects the owner and superintendent to decide "which pharmacist is accountable and responsible for each part of the service". They must make sure remote staff are competent. They must control access to records, "including how they are stored, kept and removed". And personal data must sit on servers in the UK or a jurisdiction with equivalent protection. A pharmacist at a kitchen table with a browser tab open to the PMR is inside the regulated system, not outside it.
Three limits follow from the same logic. The remote pharmacist cannot be counted as the RP or as the supervising pharmacist for supply. They cannot see the physical item, so the accuracy check against the dispensed product stays with someone on site. And the pharmacy record, the RP notice and the two-hour clock all refer to the person in the building. The remote check is a clinical safeguard on top of the on-site one, not a replacement for it.
If you want a pharmacist reviewing orders from home, write it into the service design. Say who they are, what they check, how they escalate, and how the on-site pharmacist records that the supply was supervised. If you want the RP at home, stop. There is no lawful version of that, before or after 10 December 2026. If you are the remote pharmacist, make sure your name is on the accountability map and your access to records is logged.
Can an online pharmacy operate with remote prescribers?
Yes, and the GPhC guidance assumes it will. Prescribing is a clinical act by a registered prescriber, and it can happen anywhere the prescriber can consult safely. The February 2025 guidance requires the pharmacy to check that the prescriber is registered with the relevant regulator. A prescriber outside the UK must be "registered with the relevant professional regulator in the country they are based in". The pharmacy owner and the superintendent remain responsible for the service even when the prescriber is a contractor.
The conditions are about method, not location. The guidance requires "timely two-way communication between the prescriber and the person", so the prescriber can ask for more information. For medicines on its higher-risk list, "the prescriber does not base prescribing decisions on the information provided in a questionnaire alone" and must independently verify it. For weight-loss medicines the prescriber must verify weight, height or BMI, and the guidance says a phone call "would not be appropriate". The detail is in our guide to the remote prescribing rules for high-risk medicines.
Two further points for anyone building a remote prescribing model. First, the prescriber's regulator sets its own standards. A remote GMC registrant is bound by GMC prescribing guidance, and a pharmacist independent prescriber by the GPhC's. Second, the GPhC inspects the pharmacy, not the prescriber. Its updated inspection framework, published on 13 January 2026, includes guidance on prescribing and on websites. Weak prescriber oversight shows up as a failed premises standard, not as a complaint about the prescriber.
What can other pharmacy staff do remotely?
Everything that does not touch a medicine. Order screening, customer messaging, prescription queries with surgeries, bookings, records administration, marketing and finance all sit outside the sale-and-supply rules. The GPhC guidance treats these people as part of the pharmacy team, so the same training, competence and confidentiality expectations apply. Remote does not mean unregulated.
The tasks that must stay on site cluster around the item and the counter. Assembly and labelling happen where the stock is. Accuracy checking against the dispensed product needs the product. Hand-out to the patient is a supply, and even in the pharmacist's absence it needs a person on the premises with an authorisation. Controlled drugs handling and register entries are premises-bound. And the responsible pharmacist notice, record and absence rules describe a person in the building.
| Role | Remote-capable tasks | Must stay on site |
|---|---|---|
| Pharmacist (not the RP on duty) | Clinical review, patient consultations by phone or video, prescribing if qualified, audits, SOP work. | Supervising supply. Acting as RP. |
| Responsible pharmacist | Nothing while signed in as RP, beyond the two-hour absence rules. | The whole role. |
| Pharmacy technician | Order screening, queries, records, training. | Assembly, accuracy checks, hand-out, and from 10 December 2026 any authorised dispensing. |
| Dispenser or assistant | Customer service, bookings, admin. | Assembly, hand-out. |
| Prescriber | Consultations, prescribing decisions, monitoring. | Nothing, subject to the verification rules. |
How do the 2026 supervision changes affect remote working?
They widen what staff can do while the pharmacist is out of reach, without moving the pharmacist any further away. Since 7 January 2026 a pharmacist can authorise any member of the team to hand out checked and bagged prescriptions in the pharmacist's absence. The Order of Council made on 4 February 2026 fixed 10 December 2026 for the second phase. From that day a pharmacist can authorise registered pharmacy technicians to carry out, or supervise others carrying out, the preparation, assembly, dispensing, sale and supply of medicines.
Read the hand-out provision carefully. It applies when the pharmacist is absent or "not available to intervene" in the transaction. A pharmacist in the consultation room qualifies. A pharmacist at home does not become a supervising pharmacist by being on the phone. The absence in question is the two-hour absence of the 2008 Regulations, and the GPhC has said the changes do not extend it. Our guide to the 2026 pharmacy supervision changes covers both phases in detail.
The December powers will be authorisation-based, and an authorisation can be general or specific, oral or written, with conditions. The GPhC's draft standards expect it in writing, recorded on the day. What an authorisation cannot do is stand in for the responsible pharmacist. The GPhC's FAQs say the changes "will not change the requirement for there to be a Responsible Pharmacist on duty at each pharmacy". Nor do they "permit a pharmacy technician to perform the role". A technician-led dispensary in December still has a pharmacist signed in upstairs.
These proposals are not a move towards allowing pharmacists to remotely supervise a community pharmacy.
Does hub and spoke count as remote working?
No. It moves the assembly to another registered pharmacy, not away from registered premises. The Human Medicines (Amendments Relating to Hub and Spoke Dispensing etc.) Regulations 2025, SI 2025/758, came into force on 1 October 2025 across the UK. They allow a spoke pharmacy to send prescriptions to a hub under different ownership. The hub must itself be a registered pharmacy. It assembles the medicines and returns them to the spoke, which makes the final supply "at or from premises" of the spoke.
The regulations require "written arrangements" between hub and spoke with "a comprehensive statement of the responsibilities" of each. The spoke must display a notice naming its hub partners, on the premises or in the dispensing content of its website. The hub cannot supply direct to the patient. So every medicine in a hub and spoke chain is handled at two registered pharmacies, each with its own responsible pharmacist. That is the opposite of remote working. Our guide to the new hub and spoke dispensing rules sets out the written arrangement in full.
The same amendments clarified that the transactions in regulations 220 and 221 take place "at or from" premises, and may be completed elsewhere. That wording is what lets a distance-selling pharmacy post a medicine to a patient. It does not let the supervision of the supply leave the building.
What governance does remote working need?
The same governance as the pharmacy, extended to wherever the person sits. The GPhC's distance guidance gives the outline. Risk assessment for each service. Clear accountability for each pharmacist. Competent staff wherever they work. Controlled access to records, secure UK-based data storage, and regular audit. Employment law and data protection add their own layers. Our guides to protecting patient data and to completing the Data Security and Protection Toolkit cover the technical side.
- Map every step of each service to a named person and a location. Confirm the RP and the supervising pharmacist are on the premises.
- Write the remote pharmacist's role into the SOP: what they review, how they escalate, and how the on-site pharmacist records supervision of the supply.
- Give remote staff individual logins with role-based access, and keep the audit log of who opened which record.
- Confirm patient data stays on servers in the UK or an equivalent jurisdiction, including any video or messaging tools.
- Check every remote prescriber's registration, and record the verification method used for higher-risk and weight-loss medicines.
- Keep the RP record, notice and two-hour absences exactly as before; remote colleagues do not change them.
- Audit the remote arrangements on the same cycle as the dispensary, and include them in the risk assessment the GPhC guidance requires.
Key takeaways
- The law fixes two things: medicines are supplied at or from registered premises under a pharmacist's supervision, and a responsible pharmacist is signed in there.
- The RP may be absent for no more than two hours in business hours under the 2008 Regulations. The GPhC says the 2026 changes do not allow remote supervision.
- A pharmacist who is not the RP on duty can clinically review prescriptions remotely; the GPhC's February 2025 guidance expressly covers staff who work away from the pharmacy.
- Remote prescribers are allowed if registered with their regulator, with two-way communication and independent verification for higher-risk medicines.
- Assembly, accuracy checking of the item, hand-out and controlled drugs handling stay on the premises.
- Phase one of the supervision Order took effect on 7 January 2026; phase two commences on 10 December 2026 and still requires a signed-in RP.
- Hub and spoke, lawful across ownership since 1 October 2025, moves work between two registered pharmacies and is not remote working.
Sources and further reading
- Pharmacy supervision legislation FAQs (GPhC)
- Responsible Pharmacist Regulations 2008
- Guidance for registered pharmacies providing services at a distance (GPhC, February 2025)
- Pharmacy supervision: consultation document (DHSC, December 2023)
- Human Medicines (Amendments Relating to Hub and Spoke Dispensing etc.) Regulations 2025
- Human Medicines Regulations 2012
FAQs
Remote access, on-site control.
Remote clinical review only works if the pharmacist at home and the team in the dispensary see the same record, and the audit trail shows who did what. Dataforge PMR gives each role its own access and logs every action, wherever the user sits.
See Dataforge PMR